AIDS and HIV-Related Diseases: An Educational Guide for Professionals and the Public

AIDS and HIV-Related Diseases: An Educational Guide for Professionals and the Public

AIDS and HIV-Related Diseases: An Educational Guide for Professionals and the Public

AIDS and HIV-Related Diseases: An Educational Guide for Professionals and the Public

Synopsis

AIDS and HIV-Related Diseases: An Educational Guide for Professionals and the Public is a compelling exploration of how disease affects and "devalues" populations in our society. Mr. Powell, and expert in HIV and AIDS awareness and related public health policy, presents this important resource as a viable way to explain the "system" of disease progression and control and the complicated terms and protocols that dictate AIDS and HIV treatment, education, and social policy. With extensive appendixes and illustrative models, this fundamental handbook demystifies complicated medical language, discusses new or alternative treatments, and provides insight and direction for HIV-prevention education and counseling infected clients.

Excerpt

In recent years, there has been increased public entreaty to develop potential therapies more rapidly for many life-threatening diseases for which there are no effective medical treatments. Many patient-advocacy groups have had some success in expediting the release of new drugs from ongoing clinical trials; thus, the incentive and motivation to put pressure on the research community continues to grow. Patient-advocacy groups establish strong and oftentimes very powerful voices through demonstrations; powerful publicity tactics, and multiple interactive media. As the "information superhighway" continues to grow, it allows patient-support groups extensive access to countless individuals throughout the United States and the world.Circulating personal accounts of an afflicted individual's suffering serves to fuel the fire in terms of public support. These groups have evolved into extremely powerful assemblages by sheer virtue of their size and subsequently have met with success in influencing researchers, the pharmaceutical and biotechnology industries, and, ultimately, the division of government that sets forth the regulations governing the release of new drugs into the market.

Advocacy groups place enormous pressures on drug developers to accelerate the development (and therefore the release) of drugs, as well as expanded access to drugs under investigation. These pressures have generated many changes in the architecture of drug-development guidelines. Although it is human nature to . . .

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.